Innoveren Scientific Inc (IVRN)
Innoveren Scientific Inc. is a healthcare company focused on medical bioscience and biotechnology. Through its work in regenerative medicine, the company is developing technology aimed at limb salvage, while also advancing immunotherapy programs for ovarian cancer, pancreatic cancer, and mesothelioma. The business was previously known as H-CYTE, Inc. and adopted its current name in July 2023. Innoveren Scientific is headquartered in Tampa, Florida, and its common stock is quoted on OTC Markets under the ticker IVRN.
Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ
Jump directly to the stock analysis sections supported by the latest available data.
Data update note:
Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
| Ticker | Fair Value | Analyst Price Target | Analyst Target Upside/Downside | Overall Financial Health | Dividend Yield | Market Cap |
|---|---|---|---|---|---|---|
|
OTC-IVRN
|
Not available
|
Not available
|
Not available
|
Fair
|
0.0%
|
3.203 K
|
